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Desmoid tumours or Fibromatosis aggressiva are rare,
slow growing, histologically benign tumours of soft tissue.
Despite their benign appearance, they are locally aggressi-
ve and tend to invade surrounding structures [1]. De-
smoid tumour is a relatively rare lesion, representing less
than 0.1% of all neoplasms, with reported annual inci-
dence 2-4 cases/1 mln population [2]. About 2% of de-
smoids are FAP (Familial Adenomatous Polyposis) asso-
ciated, with mutation of APC gene and about 1000 fold in-
creased risk of developing desmoids compared to the
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A i m  a n d  p u r p o s e. Desmoid (fibromatosis aggressiva) is a rare, histologically benign but locally aggressive tumour.
Radiotherapy has an important place in the treatment of this disease, but the value of this method in paediatric patients is not
established and published results are sparse. The aim of this study is to present our experience in treating paediatric desmoid
tumours and to consider the most optimal treatment for these patients.
M a t e r i a l  a n d  m e t h o d s. Between 1991 and 2000, 9 children in age 4-14 years with desmoid tumours, were treated in the
First Radiotherapy Department of the Warsaw Cancer Center of Oncology. All patients were irradiated after nonradical
surgery and 6 due to the first or next local recurrence. The aggressive chemotherapy regimes were applied in 8 children. All pa-
tients received local irradiation for tumour bed with total doses of 50-60 Gy.
Re s u l t s. All children are alive from 10 to 112 months after completing radiotherapy. In 2 patients local relapses after 8 and
18 months were observed. Five patients are living with no evidence of disease more than two years after radiotherapy. The
growth arrest and other serious complications after radiotherapy were not observed.
C o n c l u s i o n s. The treatment of a child with desmoid tumour should be considered individually. Surgery is a treatment of
choice, and adjuvant radiotherapy with doses of 50-60 Gy should be applied when the potential morbidity of a second ope-
ration is high. Chemotherapy with „low toxicity” agents could be considered in patients with gross residual disease and in tho-
se with recurrent tumours.
Desmoid tumor w pediatrii: zastosowanie radioterapii
Po d s t a w a  i c e l  p r a c y. Desmoid (w∏ókniakowatoÊç) jest rzadkim, histologicznie ∏agodnym, lecz miejscowo agresywnym
guzem. Radioterapia zajmuje istotne miejsce w leczeniu tego schorzenia, ale ocena roli tego typu terapii u dzieci nie jest usta-
lona, a doniesienia w literaturze sà rzadkie. Celem tego opracowania jest przedstawienie doÊwiadczeƒ Zak∏adu Radioterapii
w leczeniu pacjentów pediatrycznych i rozwa˝enie najbardziej optymalnego sposobu leczenia dla tych chorych.
M a t e r i a ∏  i m e t o d y. W latach 1991-2000, w I Zak∏adzie Radioterapii Centrum Onkologii w Warszawie leczono 9 dzie-
ci w wieku od 4 do 16 lat, z rozpoznaniem desmoidu. Wszyscy pacjenci byli napromieniani, po nieradykalnym zabiegu ope-
racyjnym, a 6 z powodu pierwszej lub kolejnej wznowy. U 8 dzieci zastosowano równie˝ agresywnà chemioterapi´. Pacjenci by-
li napromieniani na obszar lo˝y guza w dawkach 50-60 Gy.
W y n i k i. Wszystkie dzieci ˝yjà przez okres od 10 do 112 miesi´cy od zakoƒczenia radioterapii. U 2 pacjentów stwierdzono
wznow´ po up∏ywie 8 i 18 miesi´cy. Pi´cioro dzieci ˝yje bez objawów nawrotu ponad 2 lata po napromienianiu. Nie obserwu-
je si´ u nich zaburzeƒ wzrostu, ani innych powa˝nych komplikacji po radioterapii.
W n i o s k i. Leczenie dziecka z rozpoznaniem desmoidu powinno byç rozpatrywane indywidualnie. Leczenie chirurgiczne jest
metodà z wyboru; uzupe∏niajàca radioterapia w dawkach 50-60 Gy powinna byç zastosowana u pacjentów z wysokim ryzy-
kiem okaleczenia po reoperacji. Chemioterapia z zastosowaniem leków o „niskiej toksycznoÊci” mo˝e byç rozpatrywana u ma-
∏ych dzieci z du˝à pozosta∏oÊcià guza oraz w przypadkach nawrotu.
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general population, especially with intraabdominal locali-
sation [3]. An association between trauma and hormonal
status (pregnancy) has been also reported [4, 5]. Desmoid
tumours are localised most often in the extremities, neck,
trunk, abdominal wall and in the small bowel mesentery [3,
6, 7]. The treatment of choice for most of these tumours is
a wide local excision, but local failures after surgical treat-
ment are often observed, from 5 to 50% after microscopi-
cally complete resection to 60-90% after incomplete surge-
ry [6, 8-10]. For patients treated with combined incom-
plete resection and radiotherapy, relapse rate is diminished
to 20-40% [1, 5-7, 9, 10]. The role of adjuvant chemothera-
py has not been established in any prospective, randomised
study, although some authors reported stabilisation and re-
mission in single cases [4, 6]. A number of drugs that are
not classical antineoplastic agents have been used: nonste-
roid anti-inflammatory drugs, ascorbic acid, vitamin K,
antiestrogens etc. with occasional benefit in largely anec-
dotal reports [11, 12]. Most published articles included
adult patients alone or adult and paediatric population
together; reports related to treatment of desmoid in chil-
dren are sparse [4, 8, 12].
The aim of this study is to present our experience in
treating paediatric patients with desmoid tumours, and to
consider the most optimal ways of treatment.
Material and Methods
From 1991 till 2000, 9 children, aged 4-16 (median 12) with histo-
patollogically confirmed diagnosis of desmoid tumour (Fibro-
matosis aggresiva) received irradiation in the First Radiotherapy
Department of the Warsaw Cancer Center. In all cases microsco-
pically or macroscopically nonradical excision was performed.
Three children were irradiated immediately after nonradical
surgery, in remaining 6 radiotherapy was applied due to first or
next relapse. Two girls were treated with multiple surgery proce-
dures for 5 times. Eight children but one were treated before ra-
diotherapy with aggressive chemotherapy regimes, usually used
in malignant sarcomas. This treatment was applied in paediatric
oncology departments before they were reffered to our Center.
All patients received radiotherapy with Co-60 or mixed pho-
ton and electron beams. The treatment was planned with the use
of simulator, and 2 opposite or oblique beams with wedges were
applied. In 4 patients treated after 1996, the conformal radiothe-
rapy was performed, with CT and 3-D treatment planning and in-
dividual shielding. The total doses were 50-60 Gy, and fractiona-
tion doses 1.8 Gy. The tolerance of treatment was good, only
mild skin reactions (RTOG I) in all patients were observed.
Results
All patients are alive from 10 to 112 months after comple-
ting radiotherapy. In 2 children local recurrences after 8
and 18 months were observed, one of them is living after
forearm amputation, the second after next nonradical re-
section, with stable disease. Two patients, treated with
multiple surgery and with gross residual tumours, are ob-
served up to 12 months, with slow partial regression of tu-
mour. Patients' characteristics, methods of treatment and
results are presented in Table I.
Late side effects of treatment are mostly connected
with surgical treatment. The growth arrest and serious
soft tissue complications after radiotherapy were not ob-
served. Two girls, treated with mutilating surgery and in-
tensive chemotherapy, suffer from serious postsurgical
complications, one of them has a shortening and deforma-
tion of leg.
Discussion
Desmoid tumours (Fibromatosis Aggressiva) are a hetero-
geneous group a benign fibrous proliferation. Multiple
recurrences often occur, but deaths due to this disease are
rare (in 0-8% cases) mostly in head and neck or mesente-
ric localisation [3, 8]. There are many reports describing
prognostic factors and methods of treatment. The treat-
ment of choice is surgery, but recurrence rate is high.
Groups of patients, (from 13 to 190 cases), presented in
the literature consist of adults and children together. In
many reports the most important prognostic factor, that
independently predicts for local recurrence is a surgically
positive margin [5-9]. However some authors do not con-
firm this observation [1]. Adjuvant radiotherapy is connec-
ted with improvement of local results in patients with po-
sitive surgical margins, after partial surgery, and also in
patients treated nonsurgically [5-7, 9, 10, 13]. A sufficient
portals of irradiation, encompassing whole tumour bed
for avoiding „geographical misses” and doses range 50-60
Gy are mandatory [1, 5, 7, 9, 10, 13]. The group of 9 pa-
tients, treated with combined surgery and radiotherapy,
was presented in Polish literature [14]. The local control
was obtained in 7 patients. Authors suggested doses of 56
Gy in radiation therapy when used as only modality of
treatment, and of 50 Gy in postoperative irradiation. So-
me authors, emphasize also young age (below 18 or 30
years) and plantar localisation as a negative prognostic
factor [4, 6, 10]. The largest paediatric series (63 chil-
dren) with desmoid tumour was reported from Memorial
Sloane Kettering Cancer Centre [8]. The basic method of
treatment was surgical resection. Recurrence at 3 years
was observed in 75% of patients. Radiotherapy was ap-
plied in 11 patients, but only in 5 with doses higher than
50 Gy. Four children recurred, including 2 of 5, who rece-
ived doses above 50 Gy. Six patients received chemothe-
rapy, and of the four patients with at least 3 years fol-
low-up, two recurred. Authors from St. Jude Chil-
dren's Research Hospital presented long-term results with
radiation therapy in 13 children with desmoid tumours
[15]. Up to now it is the largest series of paediatric pa-
tients, treated with radiotherapy and with median follow-
-up of 198 months. In this group 10/13 children recur-
red, but only 1 later than 32 months after irradiation, and
3 have died from their disease. The failure rate with radia-
tion therapy in this group was high, and authors specula-
te, that these tumours in children are biologically different
from their adult counterpart.
In our material all patients were irradiated due to
nonradical excision and 6 with recurrent tumour. Two
girls were treated with multiple surgery, and in one of
them this treatment was a cause of serious morbidity. In
these patients we observed a slow partial regression of
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residual tumour. The slow response of desmoid tumour
after radiotherapy has been reported [15]. In all children
but one aggressive chemotherapy was applied, without
any therapeutic effect. Relapse free survival >2 years
was obtained in 5/7 patients, in 2 children follow-up is
shorter. These results are similar as presented by others
[3-6, 9, 10] and better than reported by St. Jude Hospital
team [15], but long-term observations are necessary. The
doses ranging from 50 to 60 Gy were well tolerated, and
up to now we do not observe any serious complications
related to radiotherapy.
According to our experience and literature data we
suggest, that treatment for children with desmoid sho-
uld be considered individually. Surgery is a treatment of
choice, and, when negative margins can be achieved, no
additional therapy is indicated. Even if the surgical mar-
gins are minimally positive, many patients will not have
a recurrence.Tumours that are incompletely resected are
treated adjuvantly, when the potential morbidity of a re-
excision is high. Under these circumstances adjuvant ra-
diation therapy is used and the doses above 50 Gy are
recommended. Radiation portals should be adequate to
encompass whole tumour bed with 5 cm margin. Che-
motherapy could be an alternative to radiation therapy
especially for young children, but the systemic use of such
toxic drugs as alkylating agents and anthracycline is diffi-
cult to justify for a tumour that is only locally aggressive.
Alternative to these agents are drugs with relatively „low
toxicity”, such as vinblastine and methotrexate. These
agents are the subject of Pediatric Oncology Group trial
for patients with gross residual tumour after surgery and
for those with recurrence.
Conclusions
The treatment of pediatric desmoid tumour should be
considered individually by a multidisciplinary team. Sur-
gery is a treatment of choice, and adjuvant radiotherapy in
doses 50-60 Gy should be applied after nonradical surge-
ry, when the potential morbidity of a second operation is
high. Chemotherapy with „low toxic” agents could be
considered in young children with gross residual disease
and in those with recurrent tumours.
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Tab. I. Patients' characteristics, methods of treatment and results in children with desmoid treated in Radiotherapy Department,
Center of Oncology, Warsaw
N Age Sex Localisation Treatment Recurrence RT Recurrence Treatment Present Months
before RT / year before RT / year year after RT of recurrence status after RT
/months
1 12 M shank NS 1990 no 1991 no - NED 112
Chth 1990
2 9 M buttock RS 1988 yes 1993 1993 no - NED 89
NS 1993
3 5 M forearm NS 1993 no 1993 yes 8 amputation NED 86
Chth 1993 
4 7 F groin NS 1991 yes 1995 1995 no - NED 57
Chth 1995
NS 1995
5 4 M abdominal wall Chth 1996 no 1996 no - NED 50
NS 1996
6 16 F popliteal fossa NS 1997 yes 1998 1998 yes 18 NS SD 32
Chth 1998
NS 1998
7 11 M arm NS 1997 yes 1998 1998 no - NED 25
Chth 1997
NS 1998
8 14 F extremites NS 1994 yes 1995-1999 2000 no - PR 12
inferior (plantar NS 4x 1995-1999
to buttock) Chth 1999-2000
9 14 F abdominal wall NS 1992 yes 1998 2000 no - PR 10
Chth 1992
NS 3x 1998
Chth 2000
Abbreviations: RS – radical surgery, NS – nonradical surgery, Chth – chemotherapy, RT – radiotherapy, NED – non evidence disease, SD – stable
disease, PR – partial regression
References
1. Merchant N, Lewis J, Woodruff J et al. Extremity and trunk desmoid tu-
mours. Cancer 1999; 86: 2045-2052.
2. Plukker J, Van Oort J, Vermey A et al. Aggressive fibromatosis (non fami-
lial desmoid tumor): therapeutic problems and the role of adjuvant radio-
therapy. British J Surgery 1995; 82: 510-514.
3. Clark S, Philips R. Desmoids in familial adenomatous polyposis. British
J Surgery 1996; 83: 1494-1504.
4. Skapek S, Hawk B, Hoffer F et al. Combination chemotherapy using
vinblastine and methotrexate for the treatment of progressive desmoid tu-
mour in children J Clin Oncol 1998; 16: 3021-3027.
5. Spear M, Jennings C, Mankin H et al. Individualizing management of ag-
gressive fibromatosis. Int J Rad Oncol Biol Phys 1998; 40: 637-645.
6. Goy B, Lee S, Eibler F, et al. The role of adjuvant radiotherapy in the tre-
atment of resectable desmoid tumors. Int J Rad Oncol Biol Phys1997; 39:
659-665.
7. Ballo M, Zagars G, Pollack A et al. Desmoid tumor: prognostic factors
and outcome after surgery, radiation therapy, or combined surgery and ra-
diation therapy. J Clin Oncol 1999; 17: 158-167.
8. Faulkner L, Hajdu S, Kher C et al. Pediatric desmoid tumour: retrospec-
tive analysis of 63 cases. J Clin Oncol 1995; 13: 2813-2818.
9. Ballo M, Zagras G, Pollack A. Radiation therapy in the management of
desmoid tumours. Int J Rad Oncol Biol Phys 1998; 42: 1007-1014.
10. Kamath S, Parsons J, Marcus R et al. Radiotherapy for local control of ag-
gressive fibromatosis. Int J Rad Oncol Biol Phys 1996; 36: 325-328.
11. Leithner A, Schnack B, Ketterschafhe T et al. Treatment of extraabdomi-
nal desmoid tumours with interferon-alpha with or without Tretinoin.
J Surgical Oncology 2000; 73: 21-25.
12. Lackner H, Urban C, Kerbl R. Noncytotoxic drug therapy in children
with unresectable desmoid tumours. Cancer 1997; 80: 334-340.
13. Catton C, O'Sullivan B, Bell R at al. Aggressive fibromatosis: optimisation
of local management with a retrospective failure analysis. Radiotherapy
and Oncology 1995; 34: 17-22.
14. Prejbisz J, Bujko K. Tumor desmoides: zastosowanie radioterapii. No-
wotwory 1986; 36: 59-54.
15. Merchant T, Nguyen B, Walter A et al. Long-term results with radiation
therapy for paediatric desmoid tumours. Int J Rad Oncol Biol Phys 2000;
47: 1267-1271.
Paper received: 7 February 2001
Accepted: 13 March 2001
248
